Back to search

National and Kapodistrian University of Athens

HIV και ήπαρ

Abstract

dc:description

The introduction of antiretroviral treatment (ART) for HIV-infected patients has led to a change of these patients' life expectancy, making HIV infection a chronic rather than a fatal disease. This prolongation of patients' survival has resulted in a change of the diseases most commonly seen during HIV infection's natural course, with cardiovascular and liver disease presenting more often than opportunistic infections. As far as liver is concerned, diseases like chronic HBV and HCV infections lead to liver cirrhosis faster in patients with HIV infection, while the prevalence of alcoholic and non-alcoholic disease is steadily rising in these patients. The best method for assesing liver fibrosis is liver biopsy; however it is an invasive procedure that requires hospitalization and is prone to complications. For that reason, non invasive methods for assesing liver fibrosis have been developed; among them transient elastography, measuring liver stifness, seems to provide the most reliable results with high creditability. Transient elastography, however, has also limitations, like high cost, low availability, especially in low income countries, and dependence on operator experience. For that reason various scores have been developed that take into account commonly used laboratory results for determining liver fibrosis. The use of these, so called non-invasive biomarkers of liver disease, in specific groups of patients like those suffering for hepatitis C virus are trustworthy and can replace transient elastography in everyday practice. Even though the application of these non-invasive biomarkers in the general population and patients with HIV/HCV infection is widespread, few studies exist in patients with HIV infection. The aim of the present study was to search for possible risk factors for significant liver fibrosis in a cohort of HIV-infected patients, as well as which non-invasive biomarkers can better determine liver fibrosis in HIV-monoinfected patients. Furthermore we tried to evaluate the efficacy of the new, all oral, treatment against HCV infection in patients with HIV/HCV coinfection. Our study included patients followed by the outpatient liver and the outpatient infectious diseases clinics of the Pathophysiology Department of 'Laiko' General Hospital. As gold standard method for determining liver fibrosis, transient elastography was used.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Androutsakos, Theodoros
  • Ανδρουτσάκος, Θεόδωρος

Subjects

dc:subject × 12

Rights

dc:rights
Statement dc:rights
  • BY
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/46948

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Androutsakos, Theodoros; Ανδρουτσάκος, Θεόδωρος. HIV και ήπαρ. National and Kapodistrian University of Athens, 2020. http://hdl.handle.net/10442/hedi/46948